Title:
肝再生・修復制御剤
Document Type and Number:
Japanese Patent JP4852773
Kind Code:
B2
Abstract:
The present invention relates to uses of PCI, which inhibits HGFa activity, and to uses of anti-PCI antibodies, which neutralize HGFa inhibition; and to agents for regulating and controlling tissue regeneration and/or repair, with PCI as an active ingredient; and to agents for enhancing tissue regeneration and/or repair, with anti-PCI antibodies as active ingredients (particularly, anti-PCI antibodies with the action of neutralizing PCI (anti-PCI neutralizing antibodies)).
Inventors:
Koji Suzuki
Hiroyuki Saito
Hiroyuki Saito
Application Number:
JP2006540926A
Publication Date:
January 11, 2012
Filing Date:
October 11, 2005
Export Citation:
Assignee:
Mie University
Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd.
International Classes:
A61K39/395; A61P1/16
Other References:
Database PubMed on internet,2004年 4月,PMID:15086199,URL,http://www.ncbi.nlm.nih.gov/pubmed?term=15086199
Fibrinolysis & Proteolysis,2000年,Vol.14, No.2/3,pp133-145
Fibrinolysis & Proteolysis,2000年,Vol.14, No.2/3,pp133-145
Attorney, Agent or Firm:
Hatsushi Shimizu
Koichi Niimi
Koichi Niimi